|
1
|
Jemal A, Tiwari RC, Murray T, Ghafoor A,
Samuels A, Ward E, et al: Cancer statistics, 2004. CA Cancer J
Clin. 54:8–29. 2004. View Article : Google Scholar
|
|
2
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
3
|
Sklenicka S, Gardiner S, Dierks EJ, Potter
BE and Bell RB: Survival analysis and risk factors for recurrence
in oral squamous cell carcinoma: does surgical salvage affect
outcome? J Oral Maxillofac Surg. 68:1270–1275. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsantoulis PK, Kastrinakis NG, Tourvas AD,
Laskaris G and Gorgoulis VG: Advances in the biology of oral
cancer. Oral Oncol. 43:523–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miller CS and Johnstone BM: Human
papillomavirus as a risk factor for oral squamous cell carcinoma: a
meta-analysis, 1982–1997. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 91:622–635. 2001.PubMed/NCBI
|
|
6
|
Scully C and Bagan J: Oral squamous cell
carcinoma overview. Oral Oncol. 45:301–308. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gold KA, Lee HY and Kim ES: Targeted
therapies in squamous cell carcinoma of the head and neck. Cancer.
115:922–935. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Corvò R: Evidence-based radiation oncology
in head and neck squamous cell carcinoma. Radiother Oncol.
85:156–170. 2007.PubMed/NCBI
|
|
9
|
Bernier J: Current state-of-the-art for
concurrent chemoradiation. Semin Radiat Oncol. 19:3–10. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bellacosa A, Kumar CC, Di Cristofano A and
Testa JR: Activation of AKT kinases in cancer: implications for
therapeutic targeting. Adv Cancer Res. 94:29–86. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cicenas J: The potential role of Akt
phosphorylation in human cancers. Int J Biol Markers. 23:1–9.
2008.PubMed/NCBI
|
|
12
|
Molinolo AA, Amornphimoltham P, Squarize
CH, Castilho RM, Patel V and Gutkind JS: Dysregulated molecular
networks in head and neck carcinogenesis. Oral Oncol. 45:324–334.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okumura K, Mendoza M, Bachoo RM, DePinho
RA, Cavenee WK and Furnari FB: PCAF modulates PTEN activity. J Biol
Chem. 281:26562–26568. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steck PA, Pershouse MA, Jasser SA, Yung
WK, Lin H, Ligon AH, et al: Identification of a candidate tumour
suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in
multiple advanced cancers. Nat Genet. 15:356–362. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kurasawa Y, Shiiba M, Nakamura M, Fushimi
K, Ishigami T, Bukawa H, et al: PTEN expression and methylation
status in oral squamous cell carcinoma. Oncol Rep. 19:1429–1434.
2008.PubMed/NCBI
|
|
16
|
Lundberg AS and Weinberg RA: Control of
the cell cycle and apoptosis. Eur J Cancer. 35:531–539. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
el-Naggar AK, Steck K and Batsakis JG:
Heterogeneity of the proliferative fraction and cyclin D1/CCND1
gene amplification in head and neck squamous cell carcinoma.
Cytometry. 21:47–51. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuzak TJ, Rist L, Eggenschwiler J, Grotzer
MA and Viviani A: Paediatric medulloblastoma cells are susceptible
to Viscum album (mistletoe) preparations. Anticancer Res.
26:3485–3492. 2006.PubMed/NCBI
|
|
19
|
Harmsma M, Grommé M, Ummelen M, Dignef W,
Tusenius KJ and Ramaekers FC: Differential effects of Viscum
album extract Iscador Qu on cell cycle progression and
apoptosis in cancer cells. Int J Oncol. 25:1521–1529. 2004.
|
|
20
|
Goedings P: Über die bildung von Viscum
album L. Element der Naturwissenschaft. 67:1–23. 1997.(In
German).
|
|
21
|
Molassiotis A, Scott JA, Kearney N, Pud D,
Magri MS, et al: Complementary and alternative medicine use in
breast cancer patients in Europe. Support Care Cancer. 14:260–267.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eggenschwiler J, Patrignani A, Wagner U,
Rehrauer H, Schlapbach R, Rist L, et al: Gene expression profiles
of different breast cancer cells compared with their responsiveness
to fermented mistletoe (Viscum album L.) extracts Iscador
from oak (Quercus), pine (Pinus), white fir
(Abies) and apple tree (Malus) in vitro.
Arzneimittelforschung. 56:483–496. 2006.PubMed/NCBI
|
|
23
|
Urech K, Buessing A, Thalmann G,
Schaefermeyer H and Heusser P: Antiproliferative effects of
mistletoe (Viscum album L.) extract in urinary bladder
carcinoma cell lines. Anticancer Res. 26:3049–3055. 2006.
|
|
24
|
Matthes H, Friedel WE, Bock PR and Zänker
KS: Molecular mistletoe therapy: friend or foe in established
anti-tumor protocols? A multicenter, controlled, retrospective
pharmaco-epidemiological study in pancreas cancer. Curr Mol Med.
10:430–439. 2010. View Article : Google Scholar
|
|
25
|
Maier G and Fiebig HH: Absence of tumor
growth stimulation in a panel of 16 human tumor cell lines by
mistletoe extracts in vitro. Anticancer Drugs. 13:373–379. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pedrero JM, Carracedo DG, Pinto CM,
Zapatero AH, Rodrigo JP, Nieto CS, et al: Frequent genetic and
biochemical alterations of the PI3K/Akt/PTEN pathway in head and
neck squamous cell carcinoma. Int J Cancer. 114:242–248. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng JQ, Ruggeri B, Klein WM, Sonoda G,
Altomare DA, Watson DK and Testa JR: Amplification of Akt2 in human
pancreatic cells and inhibition of Akt2 expression and
tumorigenicity by antisense RNA. Proc Natl Acad Sci USA.
93:3636–3641. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brazil DP, Yang ZZ and Hemmings BA:
Advances in protein kinase B signalling: AKTion on multiple fronts.
Trends Biochem Sci. 29:233–242. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Diehl JA, Zindy F and Sherr CJ: Inhibition
of cyclin D1 phosphorylation on threonine-286 prevents its rapid
degradation via the ubiquitin-proteasome pathway. Genes Dev.
11:957–972. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sauter ER, Nesbit M, Litwin S,
Klein-Szanto AJ, Cheffetz S and Herlyn M: Antisense cyclin D1
induces apoptosis and tumor shrinkage in human squamous carcinoma.
Cancer Res. 59:4876–4881. 1999.PubMed/NCBI
|
|
31
|
Baldin V, Lukas J, Marcote MJ, Pagano M
and Draetta G: Cyclin D1 is a nuclear protein required for cell
cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Altomare DA and Testa JR: Perturbations of
the AKT signaling pathway in human cancer. Oncogene. 24:7455–7464.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Andjelkovic M, Alessi DR, Meier R,
Fernandez A, Lamb NJ, Frech M, et al: Role of translocation in the
activation and function of protein kinase B. J Biol Chem.
272:31515–31524. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nicholson KM and Anderson NG: The protein
kinase B/Akt signaling pathway in human malignancy. Cell Signal.
14:381–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen WH, Balajee AS, Wang J, Wu H, Eng C,
Pandolfi PP, et al: Essential role for nuclear PTEN in maintaining
chromosomal integrity. Cell. 128:157–170. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Trotman LC, Wang X, Alimonti A, Chen Z,
Teruya-Feldstein J, Yang H, et al: Ubiquitination regulates PTEN
nuclear import and tumor suppression. Cell. 128:141–156. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Perren A, Komminoth P, Saremaslani P,
Matter C, Feurer S, Lees JA, et al: Mutation and expression
analyses reveal differential subcellular compartmentalization of
PTEN in endocrine pancreatic tumors compared to normal islet cells.
Am J Pathol. 157:1097–1103. 2000. View Article : Google Scholar
|
|
39
|
Gimm O, Perren A, Weng LP, Marsh DJ, Yeh
JJ, Ziebold U, et al: Differential nuclear and cytoplasmic
expression of PTEN in normal thyroid tissue, and benign and
malignant epithelial thyroid tumors. Am J Pathol. 156:1693–1700.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cully M, You H, Levine AJ and Mak TW:
Beyond PTEN mutations: the PI3K pathway as an integrator of
multiple inputs during tumorigenesis. Nat Rev Cancer. 6:184–192.
2006. View Article : Google Scholar : PubMed/NCBI
|
